Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy
Journal of Nuclear Medicine · 2026
DOI: 10.2967/jnumed.126.272126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Alexandra Paule und 8 weiteren Autor:innen. Beteiligte Einrichtung: Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Magnetic Resonance Imaging, Multimodal Imaging. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
18F-PSMA PET/CT and pelvic MRI are useful for assessing biochemical recurrence of prostate cancer after prostatectomy. We evaluated the role of 18F-PSMA PET/MRI in a 1-stop-shop protocol combining a single injection of 18F-PSMA, followed by pelvic PET/multiparametric MRI (mpMRI) and whole-body PET/CT acquisitions for the detection of recurrent disease.
Methods
We evaluated 106 consecutive patients referred to our institute for biochemical recurrence after prostatectomy using a 1-stop-shop protocol comprising whole-body 18F-PSMA PET/CT and pelvic 18F-PSMA PET/mpMRI. Each imaging modality was reviewed in a blinded manner by 2 independent, experienced readers. 18F-PSMA PET/MRI, with positivity on either MRI or PSMA PET, served as the reference standard.
Results
18F-PSMA PET/MRI detected more local recurrences (n = 52, 49.06%) compared with 18F-PSMA PET/CT (n = 42, 39.62%) and mpMRI (n = 46, 43.00%). Discordant cases accounted for 18 patients (17%): 10% were positive only on MRI and 7% only on PSMA PET. Compared with 18F-PSMA PET/MRI, both mpMRI and 18F-PSMA PET demonstrated similar performance, with sensitivities of 88.5% and 78.8% and specificities of 100% and 98.1%, respectively.
Conclusion
18F-PSMA PET/MRI outperformed PET/CT and mpMRI in the detection of local recurrences of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France.
- Nuclear Imaging, CHU Timone, Marseille, France.
- Urology Department, CHU Martinique, Martinique, France; and.
- Oncology Department, CHU Martinique, France.
- Caribbean Institute of Nuclear Imaging, ICIN, CHU Martinique, Martinique, France; kwfard@gmail.com karim.fard@chu-martinique.fr.
- INSERM 1144, Université Paris Cité, Paris, France.
Zitieren
APA
Paule, A., Masson, S., Rose Dite Modestine, J., Kara, N., Taieb, D., Colomba, E., Crespel, G., D'Abadie, P., & Fard, K. (2026). Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272126
Vancouver
Paule A, Masson S, Rose Dite Modestine J, Kara N, Taieb D, Colomba E, et al. Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.126.272126
BibTeX
@article{Paule2026,
author = {Paule, Alexandra and Masson, Soizic and Rose Dite Modestine, Johan and Kara, Norelyakin and Taieb, David and Colomba, Emeline and Crespel, Guillaume and D'Abadie, Philippe and Fard, Karim},
title = {Role of 18 F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy},
journal = {Journal of Nuclear Medicine},
year = {2026},
doi = {10.2967/jnumed.126.272126}
}
EUVIMED